Managed Care Strategies to Support Access to CAR T-Cell Therapy
This live webinar will examine recent studies for approved and emerging chimeric antigen receptor-modified T cell (CAR T-cell) therapies and the impact of these treatments on the future paradigm of cancer care.
Continuing the Conversation | HER2+ Metastatic Breast Cancer and What Targeted Therapy Means for Managed Care
This CE accredited article will analyze evolving guideline recommendations for patient management in the treatment of HER2+ metastatic breast cancer
Immune Checkpoint Inhibitor/Chemotherapy Combinations for Metastatic Triple-Negative Breast Cancer: Emerging Clinical Data and Managed Care Considerations
This activity will determine the biological rationale for available and emerging treatment strategies involving immune checkpoint inhibitor (ICI)/chemotherapy combinations for the treatment of metastatic triple-negative breast cancer (mTNBC)
New and Emerging Management Strategies for Acute Graft-Versus-Host Disease in Hematopoietic Stem Cell Transplant
This activity will review clinical data for new and emerging strategies in aGVHD prevention and treatment, the role of biomarkers, and the role of the pharmacist in patient care.